Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

InspireMD (NSPR) Accumulated Depreciation & Amortization (2012 - 2025)

InspireMD posted quarterly Accumulated Depreciation & Amortization of $476.0 million for Q4 2025, up 70.0% year-on-year from $280.0 million in Q4 2024, and up 70.0% on a QoQ basis from $280.0 million in Q4 2024.

InspireMD (NSPR) has 14 years of Accumulated Depreciation & Amortization data on file, last reported at $476.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 70.0% year-over-year to $476.0 million; the trailing twelve-month figure through Dec 2025 stood at $476.0 million (up 70.0% YoY), and the FY2025 full-year result was $476.0 million, up 70.0% from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 stood at $476.0 million, up from $280.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $476.0 million in Q4 2025 and bottomed at $1.7 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $232.0 million (2023), against an average of $235.5 million.
  • The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 10779.63%; it then rose 20.69% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.7 million in 2021, then jumped by 10779.63% to $188.0 million in 2022, then grew by 23.4% to $232.0 million in 2023, then climbed by 20.69% to $280.0 million in 2024, then soared by 70.0% to $476.0 million in 2025.
  • The last three Accumulated Depreciation & Amortization figures came in at $476.0 million (Q4 2025), $280.0 million (Q4 2024), and $232.0 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 476.00 Mn
Dec 31, 2025 476.00 Mn
Dec 31, 2024 280.00 Mn
Dec 31, 2024 280.00 Mn
Dec 31, 2023 232.00 Mn
Dec 31, 2023 232.00 Mn
Dec 31, 2022 188.00 Mn
Dec 31, 2022 188.00 Mn
Dec 31, 2021 1.73 Mn
Dec 31, 2021 1.73 Mn
Dec 31, 2020 151,000.00
Dec 31, 2020 151,000.00
Dec 31, 2019 158,000.00
Dec 31, 2019 158,000.00
Dec 31, 2018 139,000.00
Dec 31, 2018 139,000.00
Dec 31, 2017 153,000.00
Dec 31, 2017 153,000.00
Dec 31, 2016 142,000.00
Dec 31, 2016 142,000.00
Dec 31, 2015 152,000.00
Dec 31, 2015 152,000.00
Dec 31, 2014 875,000.00
Dec 31, 2014 875,000.00
Jun 30, 2013 634,000.00
Jun 30, 2013 634,000.00
Jun 30, 2012 472,000.00
Jun 30, 2012 472,000.00